Transforming Growth Factor Alpha (TGF-α) is a critical biomarker associated with various malignancies and pathological conditions, including cancer and other diseases. For efficient diagnosis and therapeutic monitoring, TGF-α in clinical serum must be detected accurately. In this study, we present a highly sensitive and selective electrochemical immunosensor for the detection of TGF-α, leveraging the principles of immunorecognition and advanced signal transduction. The immunosensor was constructed by immobilizing monoclonal anti-TGF-α antibodies via EDC
NHS chemistry onto a screen-printed electrode surface modified with gold nanoparticles to enhance electron transfer and provide a high surface area for antibody binding. Gold nanomaterials were characterized by UV–Vis spectroscopy, Fourier transform infrared spectroscopy (FTIR), Dynamic light scattering (DLS), and Transmission electron microscopy (TEM) to confirm their morphology and size. Cyclic voltammetry (CV) and X-ray photoelectron spectroscopy (XPS) were employed to characterize the electrode modifications, ensuring stability and functional integrity. The developed sensor demonstrated excellent analytical performance, with a detection limit of 0.35 pg mL⁻¹, a linear range of 1–1000 pg mL⁻¹, and a high sensitivity of 0.051 mA. The immunosensor demonstrated high specificity, with negligible interference from other serum proteins, and robust repeatability. The sensor retained about 98% of its original response after storage at 4°C for 1 week, demonstrating acceptable long-term stability of the functionalized platform. This study underscores the potential of electrochemical immunosensors as a promising platform for the point-of-care diagnostics of TGF-α, enabling timely and accurate disease management. Future advancements may integrate multiplex detection capabilities and real serum analysis for broader clinical applicability and real-world applications.
扫码关注我们
求助内容:
应助结果提醒方式:
